The FDA has granted a three-month extension for Capricor Therapeutics’ Duchenne muscular dystrophy hopeful deramiocel in ...
The FDA has placed a clinical hold on RGX-121 after small nodules or cystic masses were detected in the spines of five ...
The current classifications of vaccine recommendations could imply that not all shots require the consent of patients or ...
Following a tumultuous stretch under ex-Commissioner Marty Makary, current FDA leadership is working to restore reliability, ...
Not much is known about Boehringer Ingelheim’s drug candidate, dubbed BI 3031185, though the asset has completed at least two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results